Overview & Mechanism
Inhibits NNMT (nicotinamide N-methyltransferase), increasing NAD+ and restoring SIRT1 activity, which promotes fat oxidation and reduces adipocyte hypertrophy.
Research Dosage
50โ150 mg/day
Oral or subcutaneous injection
Once daily
4โ8 weeks
Reconstitution & Storage
Often supplied as a solution; for powder, reconstitute per supplier instructions with sterile or bacteriostatic water.
Per supplier; typically room temperature for powder, refrigerate reconstituted solutions.
Safety & Side Effects
Research compound. Often stacked with NAD+ protocols. Avoid in certain hormone-sensitive conditions.
Studies
NNMT inhibition reduces adiposity
Pharmacological inhibition of NNMT with 5-amino-1MQ reduced adipocyte size and body weight in mice, suggesting a therapeutic approach for obesity.
Read studyReferences
Research Use Only
This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.